Editorial

14:49 JST, April 23, 2025

Regenerative medicine, which uses iPS (induced pluripotent stem) cells and other materials to cure diseases for which there have been no treatment methods, is now much closer to practical application. It is hoped that a treatment method will be established at an early stage and it will be used for patients.

Kyoto University Hospital has announced the results of a clinical trial in which nerve cells made from human iPS cells were transplanted into the brains of seven patients with Parkinson’s disease, who then showed improvement in their symptoms. This is a groundbreaking achievement.

Parkinson’s disease is an intractable disease that causes tremors in the limbs and slowness of movement due to a decrease in dopamine, a substance in the brain that is related to the coordination of movement. It is estimated that there are about 290,000 patients........

© The Japan News